Macitentan: First Global Approval-Reference-Cited by-同舟云学术

Macitentan: First Global Approval

Published:2013-12-03 Issue:1 Volume:74 Page:127-133
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Patel Trina,McKeage Kate

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-013-0156-6.pdf

Reference31 articles.

1. Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? Eur Respir Rev. 2013;22(129):217–26.

2. Sitbon O, Morrell N. Pathways in pulmonary arterial hypertension: the future is here. Eur Respir Rev. 2012;21(126):321–7.

3. Bolli MH, Boss C, Binkert C, et al. The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist. J Med Chem. 2012;55(17):7849–61.

4. US FDA. FDA approves Opsumit to treat pulmonary arterial hypertension [media release]. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm371362.htm . Accessed 18 Oct 2013.

5. Actellion Pharmaceutials Ltd. Actelion receives Health Canada approval of Opsumit (macitentan) for the long-term treatment of pulmonary arterial hypertension [media release]. http://www.actelion.com . Accessed 12 Nov 2013.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis of antagonist selectivity in endothelin receptors;Cell Discovery;2024-07-30

2. Differential inhibition of sildenafil and macitentan on saxagliptin metabolism;Toxicology and Applied Pharmacology;2024-05

3. Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing;Acta Pharmaceutica Sinica B;2023-11

4. Effects of bergapten on the pharmacokinetics of macitentan in rats both in vitro and in vivo;Frontiers in Pharmacology;2023-07-10

5. Efficacy and safety of macitentan for pulmonary hypertension: A meta‐analysis;The Clinical Respiratory Journal;2023-07-10